Annual Current Assets
$344.80 M
+$171.99 M+99.53%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual total current assets is currently $344.80 million, with the most recent change of +$171.99 million (+99.53%) on 31 December 2023. During the last 3 years, it has risen by +$281.68 million (+446.28%). EYPT annual current assets is now at all-time high.EYPT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$268.55 M
-$26.38 M-8.95%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly total current assets is currently $268.55 million, with the most recent change of -$26.38 million (-8.95%) on 30 September 2024. Over the past year, it has increased by +$118.39 million (+78.84%). EYPT quarterly current assets is now -22.11% below its all-time high of $344.80 million, reached on 31 December 2023.EYPT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.5% | +78.8% |
| 3 y3 years | +446.3% | +89.4% |
| 5 y5 years | +624.4% | +470.6% |
EYPT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +446.3% | -22.1% | +89.4% |
| 5 y | 5 years | at high | +726.5% | -22.1% | +574.2% |
| alltime | all time | at high | >+9999.0% | -22.1% | >+9999.0% |
EyePoint Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $268.55 M(-8.9%) |
| June 2024 | - | $294.93 M(-7.2%) |
| Mar 2024 | - | $317.71 M(-7.9%) |
| Dec 2023 | $10.38 M(+37.6%) | $344.80 M(+129.6%) |
| Sept 2023 | - | $150.16 M(-10.1%) |
| June 2023 | - | $167.12 M(+14.4%) |
| Mar 2023 | - | $146.06 M(-15.5%) |
| Dec 2022 | $7.55 M(-70.5%) | $172.81 M(-10.0%) |
| Sept 2022 | - | $192.10 M(-6.7%) |
| June 2022 | - | $205.87 M(-6.3%) |
| Mar 2022 | - | $219.63 M(-7.6%) |
| Dec 2021 | $25.63 M(-10.4%) | $237.75 M(+67.7%) |
| Sept 2021 | - | $141.78 M(-6.6%) |
| June 2021 | - | $151.83 M(-4.7%) |
| Mar 2021 | - | $159.35 M(+152.5%) |
| Dec 2020 | $28.60 M(-8.5%) | $63.12 M(+32.6%) |
| Sept 2020 | - | $47.59 M(+19.5%) |
| June 2020 | - | $39.83 M(-19.8%) |
| Mar 2020 | - | $49.69 M(+19.1%) |
| Dec 2019 | $31.25 M(+2.2%) | $41.72 M(-11.4%) |
| Sept 2019 | - | $47.06 M(-19.7%) |
| June 2019 | - | $58.57 M(+21.1%) |
| Mar 2019 | - | $48.37 M(-16.1%) |
| Dec 2018 | $30.57 M(-3.8%) | - |
| Sept 2018 | - | $57.64 M(+44.4%) |
| June 2018 | $31.76 M(+3289.6%) | $39.91 M(+125.8%) |
| Mar 2018 | - | $17.68 M(+29.5%) |
| Dec 2017 | - | $13.64 M(+8.8%) |
| Sept 2017 | - | $12.55 M(-29.3%) |
| June 2017 | $937.00 K(-43.4%) | $17.74 M(+7.7%) |
| Mar 2017 | - | $16.47 M(-11.1%) |
| Dec 2016 | - | $18.54 M(-21.1%) |
| Sept 2016 | - | $23.50 M(-21.6%) |
| June 2016 | $1.66 M(-34.5%) | $29.96 M(-12.6%) |
| Mar 2016 | - | $34.28 M(+56.8%) |
| Dec 2015 | - | $21.86 M(-13.1%) |
| Sept 2015 | - | $25.16 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $2.53 M(-24.0%) | $29.84 M(-9.8%) |
| Mar 2015 | - | $33.08 M(-11.4%) |
| Dec 2014 | - | $37.35 M(-8.2%) |
| Sept 2014 | - | $40.69 M(+110.3%) |
| June 2014 | $3.33 M(-12.0%) | $19.34 M(-13.9%) |
| Mar 2014 | - | $22.46 M(+30.4%) |
| Dec 2013 | - | $17.23 M(-9.8%) |
| Sept 2013 | - | $19.11 M(+53.3%) |
| June 2013 | $3.79 M(-18.4%) | $12.46 M(-18.0%) |
| Mar 2013 | - | $15.21 M(-9.5%) |
| Dec 2012 | - | $16.81 M(-11.1%) |
| Sept 2012 | - | $18.90 M(+18.4%) |
| June 2012 | $4.64 M(-78.7%) | $15.96 M(-10.8%) |
| Mar 2012 | - | $17.89 M(-9.9%) |
| Dec 2011 | - | $19.85 M(-10.9%) |
| Sept 2011 | - | $22.28 M(-12.2%) |
| June 2011 | $21.75 M(-9.3%) | $25.37 M(+4.2%) |
| Mar 2011 | - | $24.34 M(+42.7%) |
| Sept 2010 | - | $17.05 M(-10.4%) |
| June 2010 | $23.98 M(-17.2%) | $19.03 M(+270.9%) |
| Mar 2010 | - | $5.13 M(-15.3%) |
| Dec 2009 | - | $6.06 M(-14.6%) |
| Sept 2009 | - | $7.10 M(-12.7%) |
| June 2009 | $28.98 M(-23.9%) | $8.13 M(-13.2%) |
| Mar 2009 | - | $9.37 M(-14.1%) |
| Dec 2008 | - | $10.91 M(-17.3%) |
| Sept 2008 | - | $13.18 M(-25.5%) |
| June 2008 | $38.09 M(-60.7%) | $17.69 M(-21.0%) |
| Mar 2008 | - | $22.41 M(+70.5%) |
| Dec 2007 | - | $13.14 M(-32.1%) |
| Sept 2007 | - | $19.35 M(+239.9%) |
| June 2007 | $96.81 M(-40.3%) | $5.69 M(-7.6%) |
| Dec 2006 | - | $6.16 M(-51.4%) |
| June 2006 | $162.17 M(+174.0%) | $12.68 M(+19.9%) |
| June 2005 | $59.19 M(+886.2%) | $10.57 M(-52.0%) |
| June 2004 | $6.00 M(+52.3%) | $22.05 M(+2406.4%) |
| June 2003 | $3.94 M(+31.9%) | $879.70 K |
| June 2001 | $2.99 M | - |
FAQ
- What is EyePoint Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual current assets year-on-year change?
- What is EyePoint Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly current assets year-on-year change?
What is EyePoint Pharmaceuticals annual total current assets?
The current annual current assets of EYPT is $344.80 M
What is the all time high annual current assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual total current assets is $344.80 M
What is EyePoint Pharmaceuticals annual current assets year-on-year change?
Over the past year, EYPT annual total current assets has changed by +$171.99 M (+99.53%)
What is EyePoint Pharmaceuticals quarterly total current assets?
The current quarterly current assets of EYPT is $268.55 M
What is the all time high quarterly current assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly total current assets is $344.80 M
What is EyePoint Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, EYPT quarterly total current assets has changed by +$118.39 M (+78.84%)